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Abstract—Diabetic retinopathy (DR) and diabetic macular
edema (DME) are the leading causes of permanent blindness in
the working-age population. Automatic grading of DR and DME
helps ophthalmologists design tailored treatments to patients,
thus is of vital importance in the clinical practice. However, prior
works either grade DR or DME, and ignore the correlation be-
tween DR and its complication, i.e., DME. Moreover, the location
information, e.g., macula and soft hard exhaust annotations, are
widely used as a prior for grading. Such annotations are costly to
obtain, hence it is desirable to develop automatic grading methods
with only image-level supervision. In this paper, we present a
novel cross-disease attention network (CANet) to jointly grade
DR and DME by exploring the internal relationship between the
diseases with only image-level supervision. Our key contributions
include the disease-specific attention module to selectively learn
useful features for individual diseases, and the disease-dependent
attention module to further capture the internal relationship
between the two diseases. We integrate these two attention mod-
ules in a deep network to produce disease-specific and disease-
dependent features, and to maximize the overall performance
jointly for grading DR and DME. We evaluate our network on
two public benchmark datasets, i.e., ISBI 2018 IDRiD challenge
dataset and Messidor dataset. Our method achieves the best result
on the ISBI 2018 IDRiD challenge dataset and outperforms other
methods on the Messidor dataset. Our code is publicly available
at https://github.com/xmengli999/CANet.
Index Terms—Diabetic retinopathy, diabetic macular edema,
joint grading, attention mechanism.
I. INTRODUCTION
Diabetic Retinopathy (DR) is a consequence of microvas-
cular retinal changes triggered by diabetes. It is the most
common leading cause of blindness and visual disability in
the working-age population worldwide [1]. Structures such
as microaneurysms, hemorrhages, hard exudates, and soft
exudates are closely associated with DR and the presence of
each of the aforementioned anomaly determines the grade of
DR in the patient, as shown in Figure 1. Diabetic Macular
Edema (DME) is a complication associated with DR, which
is normally due to the accumulation of fluid leaks from blood
vessels in the macula region or retinal thickening that occurs
at any stage of DR [2]. The grading of the severity of DME
is based on the shortest distances of the hard exudates to the
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Figure 1: Early pathological signs of DR, e.g., soft exudates,
hard exudates, microaneurysms, and hemorrhage, in a diabetic
retinopathy image. Early pathological signs of DME is deter-
mined by the shortest distance of macula and hard exudates.
macula. The closer the exudate is to the macular, the more the
risk increases; see examples in Figure 2. The most effective
treatment for DR and DME is at their early stage, for example,
by laser photocoagulation. Therefore, in clinical practice, it is
important to classify and stage the severity of DR and DME,
so that DR/DME patients can receive tailored treatment at the
early stage, which typically depends on the grading.
Convolutional neural networks (CNNs) have been proven
to be a powerful tool to learn features for DR [3–5] and
DME [6, 7] grading. For example, Islam et al. [3] developed a
network to detect early-stage and severity grades of DR with
heavy data augmentation. Zhou et al. [4] presented a multi-
cell multi-task learning framework for DR grading by adopting
the classification and regression losses. Regarding the DME
grading, Ren et al. [6] presented a semi-supervised learning
method with vector quantization. These methods, however,
adopted different deep networks independently for grading
each disease, ignoring the internal relationship between DR
and DME, for example, the DME is the complication of DR.
Recently, some works began to explore joint grading of DR
and DME [8, 5]. Gulshan et al. [8] employed the Inception-v3
architecture for DR and DME grading, while Krause et al. [5]
further improved the performance by utilizing the Inception-
v4 architecture. However, these works focused on the network
design and simply regarded the joint grading task as a multi-
label problem, without considering the implicit relationship
between these two diseases. In the medical imaging com-
munity, some work [9–11] employed multi-task learning to
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Figure 2: Examples of fundus images with different pathological severity of DR and DME.
explore the relationship between different diseases (tasks). A
key factor for the success in multi-task learning is that the
information among different tasks is shared, thereby promoting
the performance of each individual task.
To explore the feature relationship of DR and DME diseases
and improve the grading performance for both diseases, it
requires an understanding of each disease, and also the
internal relationship between two diseases. To this end, we
present a novel deep network architecture, called cross-disease
attention network (CANet), to selectively leverage the features
learned by the deep convolutional neural network, and produce
disease-specific (within each disease) and disease-dependent
features (between diseases) for joint DR and DME grading.
In particular, we first develop a disease-specific attention
module to select features from the extracted feature maps
for individual disease (i.e., DR & DME). We then present
a disease-dependent attention module to explore the internal
relationship between two diseases by learning a set of attention
weights, such that a larger weight indicates a higher risk of
complication (e.g., DME may lead to worsening DR), and
vice versa. Through the attention mechanism, our network
models the implicit relationship between these two diseases,
and improves the joint grading performance.
In summary, our contributions are three folds:
• We present a novel and effective method, named as cross-
disease attention network (CANet), to jointly model the
relationship between DR and its complication, i.e., DME.
To the best of our knowledge, this is the first work for
joint modeling the disease and its complication for fundus
images.
• We propose the disease-specific attention module to se-
lectively learn useful features for individual diseases,
and also design an effective disease-dependent attention
module to capture the internal relationship between two
diseases.
• Experiments on the public IDRiD [12] challenge dataset
and the Messidor [13] dataset show that our CANet
method outperforms other methods on grading for both
diseases, and achieves the best performance on the IDRiD
dataset.
II. RELATED WORK
A. Diabetic Retinopathy Grading
Early works on automatic diabetic retinopathy grading were
based on the hand-crafted features to measure the blood ves-
sels and the optic disc, and on counting the presence of abnor-
malities such as microaneurysms, soft exudates, hemorrhages,
and hard exudates, etc. Then the grading was conducted
using these extracted features by different machine learning
methods [14–21], e.g., support vector machines (SVM) and
k-nearest neighbor (kNN) and Gaussian mixture model.
In the last few years, deep learning algorithms have be-
come popular for DR grading [22–28]. There are mainly
two categories of deep learning methods for identifying DR
severity. The first category is to use location information of
tiny lesions, e.g., microaneurysms, hemorrhage, to determine
DR grading performance. Van Grinsven et al. [29] sped up
model training by dynamically selecting misclassified negative
samples for hemorrhage detection. Dai et al. [30] proposed a
multi-modal framework by utilizing both expert knowledges
from text reports and color fundus images for microaneurysms
detection. Yang et al. [31] designed a two-stage framework for
both lesion detection and DR grading by using the annotations
of locations including microaneurysms, hemorrhage, and ex-
udates. Lin et al. [32] developed a new framework, where it
first extracted lesion information and then fused it with the
original image for DR grading. Zhou et al. [33] proposed
a collaborative learning method for both lesion segmentation
and DR grading using pixel-level and image-level supervisions
simultaneously.
The second category uses image-level supervision to train a
classification model to distinguish DR grades directly [8, 34,
35]. Gulshan et al. [8] proposed an inception-V3 network for
DR grading. Gargeya et al. [34] designed a CNN-based model
for DR severity measurements. Wang et al. [35] used attention
maps to highlight the suspicious regions, and predicted the
disease level accurately based on the whole image as well
as the high-resolution suspicious patches. It is expensive to
annotate the labels on the medical images in a pixel-wise
manner, hence, we follow the second category to conduct
disease grading with only image-level supervision.
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Figure 3: The schematic illustration of the overall cross-disease attention network (CANet). Gi and Gj denote the disease-
specific features for DR and DME, respectively; G′i and G
′
j denote the refined features with disease-dependent information
for DR and DME, respectively; r is the ratio to reduce the number of feature channels for saving parameters; fc denotes the
fully connected layer; The final loss function is the weighted combination of LDR, L′DR, LDME , and L′DME .
B. Diabetic Macular Edema Grading
Like the DR grading task, grading DME also attracts
much attention in the community [36]. The assessment of th
severity of DME is based on the distances of the exudate
to the macula. The closer the exudate is to the macular,
the more the risk increases. Early works used hand-crafted
features to represent the fundus images [37, 38]. For example,
Akram et al. [37] presented a screening system for DME that
encompassed exudate detection with respect to their position
inside the macular region. The system first extract features
for exudate candidate regions, followed by making a repre-
sentation of those candidate regions. The exact boundaries
were determined using a hybrid of GMM model. However,
the capacity of the hand-crafted features is limited. CNN based
methods [6, 7] have dramatically improved the performance
of DME grading. For example, Ren et al. [6] proposed a
semi-supervised graph-based learning method to grade the
severity of DME. Syed et al. [7] used knowledge of location
information of exudates and maculae to measure the severity
of DME. However, all of these work utilize the location
information of exudate regions for disease grading. Such an-
notations (both lesions masks and grading labels) are difficult
to obtain, in this work, we grade DME with only image-level
supervision. Under the image-level supervision,Al-Bander et
al. [39] proposed a CNN-based method based on foveae and
exudates location for DME screening. However, their method
classifies the DME into two classes, which is simpler than
ours.
C. Multi-task Learning in Medical Imaging Domain
Since jointly grading DR and DME diseases is related
to the multi-task learning, we also review related works in
medical imaging domain [40, 9–11, 41] and most of them
are designed for image classification or regression tasks. For
example, Chen et al. [9] trained a classification network for
four tasks on the Age-related Macular Degeneration disease
grading by using the CNN layers to capture common features
then fully connected layers to learn the features for individual
tasks. Liu et al. [11] employed a margin ranking loss to jointly
train the deep network for both lung nodule classification and
attribute score regression tasks. Similarly, Tan et al. [10] used
the multi-level shared features and designed individual de-
coders to jointly learn the organ probability map and regressing
boundary distance map. In contrast to these works that jointly
do classification and regression tasks, we design a novel deep
network architecture to explore the relationship between two
diseases, and improve the overall grading performance for both
diseases.
III. METHODOLOGY
Figure 3 illustrates the overview of our cross-disease atten-
tion network (CANet) for joint DR and DME grading, con-
sisting of two disease-specific attention modules (Figure 4 (a))
to learn disease-specific features and two disease-dependent
attention modules (Figure 4 (b)) to explore correlative features
between these two diseases.
A. Cross-disease Attention Network
As shown in Figure 3, our cross-disease attention network
takes a fundus image as the input and outputs the grading
scores for both DR and DME diseases in an end-to-end
manner. First, we adopt a convolutional neural network, i.e.,
ResNet50 [42] to produce a set of feature maps with different
resolutions. Then, we take the feature maps F ∈ RC×H×W
with the smallest resolution and highly-semantic information
(the deepest convolutional layer in ResNet50) as the inputs for
the following two disease-specific attention modules, which
learn the disease-specific features F′i ∈ RC×H×W and F′j ∈
RC×H×W to understand each individual disease. Note that the
feature is the one before the AvgPool and fully connected layer
of original ResNet. It contains high-level semantic information
for DR and DME. Afterwards, we propose disease-dependent
attention modules to explore the internal relationship between
the two correlative diseases and produce the disease-dependent
features for DR and DME, respectively. Finally, we predict the
grading scores for DR and DME based on the learned disease-
dependent features.
4In the following subsections, we will first elaborate the
disease-specific attention module and disease-dependent atten-
tion module in details, and then present the training and testing
strategies of our network for DR and DME grading.
B. Disease-specific Attention Module
Each disease has its specific characteristics, i.e., DR is
graded by the presence of soft exudates, hard exudates, hemor-
rhage, and microaneurysms while DME is determined by the
shortest distance between the macula and hard exudates [25].
However, the feature maps F ∈ RC×H×W extracted by
the convolutional neural network only contain the high-level
representations of the input image and it is difficult to capture
the specific characteristics for each disease. In order to learn
the representation of each individual disease, we present a
novel disease-specific attention module to learn the specific
semantic features of DR and DME, receptively.
Figure 4 (a) illustrates the detailed structure of the proposed
disease-specific attention module, which takes the feature
maps F ∈ RC×H×W as the input and adopts the channel-
wise attention as well as the spatial-wise attention to highlight
the inter-channel and inter-spatial relationship of the features
related to each disease. Specifically, we first squeeze the
spatial information from the shared feature maps F via spatial-
wise average- and max-pooling operations, and obtain two
kinds of global spatial features Fcavg and F
c
max. Then, we
feed them into a shared MLP (multi-layer perception) to
produce the channel-wise attention maps Ac. The channel-
wise attention maps Ac are described in the following:
Ac = σ[W1ReLU(W0F
c
avg)+W1ReLU(W0F
c
max)] (1)
where σ is a sigmoid function to normalize the attention
weights into [0, 1], W0 ∈ RC/r×C and W1 ∈ RC×C/r are
the weights of the shared MLP, and r is the ratio to reduce the
number of feature channels for saving the network parameters
and we empirically set it as 0.5. After obtaining the learned
attention weights Ac, we multiply it with the original feature
maps F ∈ RC×H×W to produce the disease-specific feature
maps Fi:
Fi = Ac ⊗ F , (2)
where ⊗ denotes the element-wise multiplication, and the
attention weights Ac are broadcasted along the spatial dimen-
sion. Hence, we can select the disease-specific features and
suppress the features that are irrelevant to the disease along
the feature channels.
To further highlight the disease-specific features across the
spatial domain, we follow [43, 44] and adopt another attention
model, which aggregates the channel-wise information by
applying the max-pooling and avg-pooling operations along
the channel dimension and produces the feature maps Fsi,avg
and Fsi,max. Then, we concatenate these two feature maps
together and use another convolutional operation to learn the
2D spatial-wise attention map As:
As = σ(Conv([F
s
i,avg;F
s
i,max]) , (3)
where Conv is a convolution layer and σ denotes the sigmoid
function. Finally, we obtain the disease-specific features F′i
Table I: The detailed structure of cross-disease attention
modules. “FC” represents the fully connected layer; “Conv”
represents the convolution operation; “ReLU” and “Sigmoid”
are the ReLU and Sigmoid non-linear operations, respectively;
“Concat” represents the concatenation operation. For “Conv”,
we use padding to keep the size of the feature maps. The
symbols are defined in Figure 4.
Input feature Type Output feature
di
se
as
e-
sp
ec
ifi
c
F MaxPool, Flatten Fcmax
F AvgPool, Flatten Fcavg
Fcavg , Fcmax FC 1 (2048× 128), ReLU -
- FC 2 (128× 2048) -
- Sum, Sigmoid Ac
Ac,F Multiplication Fi
Fi AvgPool Fsi,avg
Fi MaxPool Fsi,max
Fsi,avg , F
s
i,max Concat, Conv, Sigmoid As
As , Fi Multiplication F′i
di
se
as
e-
de
pe
nd
en
t Gi FC 1 (1024× 64), ReLU -
- FC 2 (64× 1024) -
- Sigmoid Ac
Ac, Gj Multiplication G′j
(F′j for another disease; see Figure 3) by multiplying the
learned attention weightsAs with the feature maps Fi to select
the disease-specific features across the spatial dimension:
F′i = As ⊗ Fi . (4)
Note that the attention weights As are broadcasted along the
channel dimension during the multiplication. In this way, we
can further selectively use the disease-specific features by
enhancing the disease-relevant features and suppressing the
disease-irrelevant features across the spatial domain.
We show the detailed structure of the disease-specific atten-
tion module in Table I. The input and output channel number
of FC 1 and FC 2 in disease-specific module are 2048× 128
and 128×2048, respectively. We use ReLu activation after the
first fully connected layer in each attention module.
C. Disease-dependent Attention Module
As the statistics of the grading labels shown in Table II and
Table III, DR and DME have the internal relationship. On the
one hand, the more exudates are, the greater risk of the macula
may have, i.e., severer of DR may lead to severer DME. On the
other hand, the closer of exudates to the macula, the more risk
of presences of pathological DR signs, i.e., worser of DME
may lead to worser DR. Motivated by this observation, we
present the disease-dependent attention module (see Figure 4
(b)) to capture the internal relationship between these two
diseases.
Table II: The statistics of the labels in the Messidor dataset.
The first number is the counts of labels and the second one is
the relative value.
DME
DR 0 1 2 3
0 546, 45.5% 142, 11.8% 182, 15.2% 104, 8.7%
1 0, 0.0% 5, 0.4% 28, 2.3% 42, 3.5%
2 0, 0.0% 6, 0.5% 37, 3.1% 108, 9.0%
5AvgPool
fc
Disease‐
specific 
attention
Disease‐
specific 
attention
AvgPool
fc
Disease‐
dependent 
attention
Disease‐
dependent
attention
Moderate NPDR
Normal
Mild NPDR
Severe NPDR
PDR
fc
fc
Sigmoid
ۯୡ
(b) Disease‐dependent attention module.
(a) The overall architecture.  
Sigmoid Conv
Sigmoid
(a) Disease‐specific attention module.
۴࢏
ᇱ ∈ Rେൈୌൈ୛
۴ ∈ Rେൈୌൈ୛
۴࢐
ᇱ ∈ Rେൈୌൈ୛
۵࢏ ∈ R
େ/୰
۵࢐ ∈ R
େ/୰
۴ ∈ Rେൈୌൈ୛ ۴࢏ ∈ R
େൈୌൈ୛
Normal
Mild
Severe
۵࢏ ∈ R
େ/୰
۵࢐ ∈ R
େ/୰ ۵࢐
ᇱ ∈ Rେ/୰
۵࢐
ᇱ ∈ Rେ/୰
۵࢏
ᇱ ∈ Rେ/୰
۴࢏
ᇱ ∈ Rେൈୌൈ୛
Moderate NPDR
ࣦ஽ோ
ᇱ
ࣦ஽ோ
ࣦ஽ொ
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ᇱ
fc
fc
۴௔௩௚
௖ ∈ Rେ
۴௠௔௫
௖ ∈ Rେ
ۯୡ ∈ R
େ
۴௜,௔௩௚
௦ ∈ Rୌൈ୛
۴௜,௠௔௫
௦ ∈ Rୌൈ୛
ۯ௦ ∈ R
ୌൈ୛
MLP
fc fc
MLP
fc fc
Figure 4: The architectures of different attention modules. The disease-specific attention module (a) exploits both the inter-
channel and inter-spatial relationship of features, while the disease-dependent module (b) explores and aggregates the informative
inter-channel features from the other branch; (b) shows an example of disease-dependent attention module used for DME
grading; Ac denotes the spatial-wise attention map and As denotes the channel-wise attention map; r is the ratio to reduce
the number of feature channels for saving parameters. The actual details of the CANet topology can be found in Table I.
Table III: The statistics of the labels in the IDRiD dataset. The
first number is the counts of labels and the second one is the
relative value.
DME
DR 0 1 2 3 4
0 134, 26.0% 18, 3.5% 36, 7.0% 5, 1.0% 4, 0.8%
1 0, 0.0% 0, 0.0% 24, 4.6% 4, 0.8% 2, 0.4%
2 0, 0.0% 0, 0.0% 140, 27.1% 116, 22.4% 33, 6.4%
As shown in Figure 3, this model takes the disease-specific
features of both DR and DME diseases as the inputs, i.e.,
Gi and Gj , which are obtained by adopting the average
pooling and fully connection operations on F′i and F
′
j , and
then it learns to produce the disease-dependent features for
DR or DME, respectively. Figure 4 (b) illustrates the detailed
structures of the proposed disease-dependent attention module
used for DME grading, which has the similar structures to the
attention model used for DR grading.
Specifically, given the feature maps Gi of DR disease, we
first employ a MLP and a sigmoid function to learn a set
of attention weights ADR, and then multiply these weights
with the input feature maps Gi to select the useful features,
which helps to identify the DME disease. After that, we add
the selected feature maps with the specific features of DME
disease Gj in an element-wise manner (⊕) to generate the
disease-dependent features of DME G′j :
ADR = σ[W
DR
1 ReLU(W
DR
0 (Gi))] , (5)
G′j = Gj ⊕ADR ⊗Gi . (6)
Hence, the network is able to capture the correlation be-
tween the DR and DME diseases and improves the overall
grading performance for both DR and DME diseases. The
detailed structure of disease-dependent attention module is
shown in Table I. The input and output channel number of
FC 1 and FC 2 are 1024×64 and 64×1024, respectively. We
use ReLu activation after the first fully connected layer in the
attention module.
D. Network Architecture
We adopted ResNet50 as the backbone network to extract
features, followed by a dropout layer with the drop rate of
0.3, and employed two disease-specific attention modules to
learn disease-specific features. We employed two loss func-
tions, i.e., L′DR and L′DME , to learn disease-specific features,
and another two loss functions, i.e., LDR and LDME , for the
final DR and DME grading:
L = LDR + LDME + λ(L′DR + L′DME), (7)
where L′DR and L′DME denote the cross-entropy loss for DR-
specific and DME-specific feature learning, respectively; LDR
and LDME denotes the loss function for the DR and DME
grading. LDR is a binary cross-entropy loss on the Messidor
dataset and a 5-class cross-entropy loss on the IDRiD dataset.
LDME is a three-class cross-entropy loss on both Messidor
and IDRiD dataset.
L(y, yˆ) = − 1
N
N∑
i=1
M∑
c=1
yci log yˆi
c (8)
where yˆic denotes the probability of voxel i belongs to
class/grade c, and yci indicates the ground truth label for retinal
image i. M is three for DME grading and two or five for DR
6grading (two in the Messidor dataset and five in the IDRiD
dataset). Taking DR as an example, we directly apply a fully
connected layer on DR-specific features Gi (batch size ×
1024) for classification. The kernel size of fully connected
layer is 1024 × 2 for Messidor dataset and 1024 × 5 for
IDRiD dataset. λ is the weight in the loss function. When
λ = 0.0, the network is optimized by the refined DR and
DME features that include both disease-specific and disease-
dependent information. As λ increasing, the framework gives
more importance to the disease-specific feature learning. We
analyze the effects of different λ in the experiment part, and
we empirically set λ as 0.25.
E. Training and Testing Strategies
We normalized the training images and resize images to
350 × 350 resolution. For data augmentation, we randomly
scaled and cropped the images into the patches with a size of
224× 224. Random horizontal flip and vertical flip were also
used to augment the training data. We optimized the network
with Adam optimizer [45]. The initial learning rate was 0.0003
and we decayed the learning rate with a cosine annealing for
each batch [46]. We trained the network for 1000 epochs and
the batch size is 40. During the training process, we feed
the samples of DR and DMR in a random order. The whole
framework was built on PyTorch [47] with Titan Xp GPU. The
network has 29 M trainable parameters. The training time of
the network was five hours and the inference time was 0.02
seconds per image.
To test the grading result, we only used the prediction score
after the refined DR and DME features, which include the
disease-dependent information. We selected the class with the
maximum prediction value in DR and DME, respectively. Dur-
ing inference, we did not use any post-processing operations
and model ensemble techniques.
IV. EXPERIMENTS AND RESULTS
A. Datasets
We evaluate the effectiveness of our method by comparing
it against existing works on Messidor dataset [13]1 and 2018
ISBI IDRiD challenge dataset [12]2. To the best of our
knowledge, these two datasets are the only two public datasets
with both DR and DME severity grading annotations.
Messidor Dataset. This dataset has 1200 eye fundus color
numerical images of the posterior pole acquired from three
ophthalmologic departments. For each image in the dataset,
its grading annotations of DR and DME are provided by the
medical experts to measure the retinopathy grade and risk of
macular edema. Specifically, DR is graded into four classes by
the severity scale. Given the fact in the DR screening that the
difference between normal images and images of stage 1 is
the most difficult task for both the CAD systems and clinical
experts, Sánchez et al. [48] grouped stages 0 and 1 of the
Messidor dataset as referable images and combined stages 2
and 3 as non-referable in their screening work. This two-class
setting has been widely used in the existing DR screening
1http://www.adcis.net/en/third-party/messidor/
2https://idrid.grand-challenge.org/Grading/
methods [49, 35], so that we conducted binary classification
for DR grading in the Messidor dataset. To fairly compare with
previous works [50, 49, 35], we use 10-fold cross validation
on the entire dataset. DME is annotated based on the shortest
distance d between the hard exudates location and the macula.
The severity of DME is graded to 0 (No visible hard exudate),
1 ( d > 1 papilla diameter), 2 ( d <= 1 papilla diameter). The
statistics of the DR and DME labels in the Messidor dataset
is shown in Table II.
IDRiD Dataset. We employed the ISBI 2018 IDRiD sub-
challenge 2 dataset. This dataset includes 516 images with a
variety of pathological conditions of DR and DME, consisting
of 413 training images and 103 test images. In the IDRiD
dataset, each image contains both DR and DME severity grad-
ing labels. DR grade is annotated into five classes according to
the severity scale, and we perform 5 class classification for DR.
DME is annotated based on the shortest distance d between the
hard exudates location and the macula. The annotation criteria
of DME grading is the same as that in the IDRiD dataset.
The statistics of the labels in the IDRiD dataset is shown in
Table III. The detailed grading criterion for the IDRiD dataset
can be found in the provided dataset websites. Note that we
report 10-fold cross validation results for the Messidor dataset
and use train & test sets split by the challenge organizers for
the IDRiD dataset.
B. Evaluation Metrics
To measure the joint grading performance, we employ the
IDRiD challenge evaluation metric “Joint Accuracy" (Joint
Ac). The definition of Joint Ac is: If the prediction matches
both DR and DME ground-truth label, then it is counted as
one, else zero. The total number of true instances is divided
by a total number of images to get the final result. We use
Joint Ac to select our final model. For the Messidor dataset,
we also report the accuracy (Ac), AUC, precision (Pre), recall
(Rec), F1-score (F1) for each disease.
For the 2018 ISBI IDRiD dataset, we follow the challenge
description and use the challenge evaluation metric (“Joint
Ac”) for comparison.
C. Analysis of Network Design
1) Compare with Baselines: We first compare our method
with two baselines, i.e., “Individual training” and “Joint train-
ing” on the Messidor dataset. “Individual training (DR)” and
“Individual training (DME)” indicates that we trained two
individual ResNet50 networks for DR and DME grading,
respectively. The “Joint training” denotes that we employed
a ResNet50 network for shared feature extraction and two
individual fully connected layers for DR and DME grading,
respectively.
Table IV reports the 10-fold cross validation results of
accuracy, AUC, precision, recall, F1-score for DR and DME
respectively, as well as Joint Ac. It is observed that “Individ-
ual training (DR)” and “Individual training (DME)” achieve
89.5% AUC and 89.1% AUC for DR and DME, respectively.
“Joint training” improves the individual training to 94.2%
7Table IV: Quantitative results on the Messidor dataset. The reported results are the mean values of 10-fold cross validation.
Ac, Pre, Rec, F1 denote accuracy, precision, recall, F1-score, respectively (unit: %).
Methods Parameters Joint Ac DR DMEAUC Ac Pre Rec F1 AUC Ac Pre Rec F1
Individual training (DR) 23.52 M - 89.5 81.0 76.2 78.9 77.3 - - - - -
Individual training (DME) 23.52 M - - - - - - 89.1 86.8 62.8 65.2 61.9
Joint training 23.52 M 82.0 94.2 89.1 86.5 88.2 87.2 90.5 90.4 78.7 73.9 75.3
Joint training (complex) 29.04 M 82.8 95.2 91.0 90.5 88.6 89.5 90.3 91.7 73.6 71.2 71.1
Joint training (complex_v2) 29.08 M 82.5 95.4 90.3 87.5 89.8 88.5 89.4 91.0 78.3 72.0 73.4
CANet (d-S only)
29.03 M
84.1 95.8 91.7 91.5 88.8 89.9 90.3 91.0 79.6 71.0 72.5
CANet (d-S; d-D DR⇒DME ) 84.5 96.0 91.7 91.5 88.7 90.0 89.4 91.9 82.3 72.0 74.8
CANet (d-S; d-D DR⇐DME ) 84.9 96.3 91.9 90.8 90.1 90.3 91.0 91.9 79.6 73.2 74.6
CANet (λ=0.25; final model) 85.1 96.3 92.6 90.6 92.0 91.2 92.4 91.2 76.3 70.8 72.4
CANet (λ=0.00)
29.03 M
84.8 96.3 92.1 92.2 88.6 90.3 91.6 91.5 82.4 73.7 75.3
CANet (λ=0.50) 84.7 96.1 91.4 89.9 89.7 89.6 92.2 92.0 78.6 74.9 75.3
CANet (λ=0.75) 84.8 96.5 92.2 92.3 88.8 90.3 91.8 92.0 79.5 71.4 73.7
CANet (λ=1.00) 84.9 96.3 92.7 91.6 90.6 91.0 90.7 91.7 77.4 69.4 71.0
AUC and 90.5% AUC for DR and DME, respectively. Notably,
our method (CANet) with the same backbone (ResNet50) and
training strategies improves the performance over these two
baselines, with 96.3% AUC (DR) and 92.4% AUC (DME).
The results show that the effectiveness of our method com-
pared with these two baselines.
From the listed model parameters in Table IV, we can see
that our method has more parameters (29.03 M), compared
with the Joint training (23.52 M). To validate the effectiveness
of our design under the same model complexity, we increase
the parameters of “joint training” to 29.04 M by adding
several standard components before classification on “joint
training”. These components include a convolutional layer
with kernel size 2048 × 300 × 3 × 3, batch normalization
layer and ReLU activation. We also implemented another
complex joint training baseline, i.e., “Joint training (com-
plex_v2)” in Table IV. This architecture is implemented by
adding three convolutional layers on “Joint training” baseline.
Specifically, the convolutional layer has the filter shapes of
2048×660×1×1, 660×512×3×3, and 512×256×3×3,
respectively. Each convolutional layer is followed by a BN and
a ReLU activation. Such complex baselines achieve 82.8% and
82.5% on joint Ac, respectively. However, with the same level
of network parameters, our method (85.1%) still achieves the
best performance, showing the effectiveness of the attention
modules.
2) Analyze the Attention Module: We analyze the effects of
disease-specific and disease-dependent attention modules. The
comparisons are conducted with the same network backbone
(ResNet50) and training strategies. The results are reported
in Table IV by the 10-fold cross validation on the Messi-
dor dataset. Compared with the “Joint training”, adding the
disease-specific attention module, i.e., “CANet (d-S only)”
enhances the Joint Ac from 82.0% to 84.1%. The accuracy
of DR and DME are also improved from 89.1% to 91.7%
(DR) and from 90.4% to 91.0% (DME), respectively. These
comparisons demonstrate that disease-specific attention mod-
ule explores more discriminative features for specific disease
grading.
Then, we analyze the importance of the disease-dependent
attention module for DME, i.e., “CANet (d-S; d-D DR⇒DME)".
This experiment indicates that the correlative feature learned
on DR is incorporated to DME branch, and vice versa. It is ob-
served that DR⇒DME improves the Joint Ac result to 84.5%,
and DME grading results are enhanced on most evaluation
metrics. Furthermore, we also analyze the importance of the
disease-dependent attention module for DR, i.e., “CANet (d-S;
d-D DR⇐DME)”. With this dependent attention branch, the joint
accuracy is boosted to 84.9%, and DR grading results are also
increased on most evaluation metrics. When we incorporate
the disease-dependent attention module into both branches, our
method “CANet (λ=0.25; final model)” achieves the highest
results, with joint Ac of 85.1%. These results validate that
the disease-specific and disease-dependent attention module
are both effective to utilize the disease-specific and disease-
dependent information for better joint grading.
3) Analyze the Weight λ in the Loss Function: We analyze
the effect of the weight λ in our method. The bottom part of
Table IV shows the results with different weights in the loss
function. When λ = 0.00, that whole framework is trained with
the final refined DR and DME features that include the both
specific and dependent information. When λ increases, the
network is trained with the additional supervision for disease-
specific attention. As shown in the Table IV, the variance
of results with different λ is little, which indicates that our
method is not very sensitive to the weight in the loss function.
Our method reaches the best “Joint Ac” result (85.1%), when
λ = 0.25. Therefore, we choose this model as our final model.
4) Analysis on Architectures: To analyze the effective-
ness of backbone models, we perform experiments on “Joint
training” to select the proper backbone architecture. The
“Joint training” denotes that we employed a backbone net-
work for shared feature extraction and two individual fully
connected layers for DR and DME grading, respectively.
We implemented with ResNet50 [42], ResNet34 [42], and
DenseNet161 [51] and the results is showed in Table VI. We
can see that ResNet50 achieves better results and finally we
use ResNet50 as the backbone model.
8Table V: Comparison with other multi-task learning methods on the Messidor dataset. The reported results are the mean of
10-fold cross validation (unit: %).
Methods Joint Ac DR DMEAUC Ac Pre Rec F1 AUC Ac Pre Rec F1
Multi-task net [9] 82.4 94.8 89.9 89.7 85.7 87.5 90.5 90.5 79.1 70.8 72.2
MTMR-Net [11] 83.1 94.9 90.3 90.0 86.7 88.1 90.6 90.4 79.8 73.2 75.4
CANet (ours) 85.1 96.3 92.6 90.6 92.0 91.2 92.4 91.2 76.3 70.8 72.4
Table VI: Results of different backbone architectures on the
Messidor dataset (unit: %).
Methods Joint Ac
ResNet50 82.0
ResNet34 81.4
DenseNet161 78.9
D. Compare with other Multi-task Learning Methods
To the best of our knowledge, there is no previous work
for joint DR and DME grading. To show the effectiveness
of our method for joint grading, we compare our method with
two recent multi-task learning methods in the medical imaging
community. Chen et al. [9] designed a method for the Age-
related Macular Degeneration disease grading, while Liu et
al. [11] proposed a network for both lung nodule classification
and attribute score regression tasks. Since these works are not
tailored for DR and DME grading, we did not directly use
their methods for joint DR and DME grading. Instead, we
adapted their key ideas to our task with the same network
backbone and training strategies for fair comparison. For [9],
after the ResNet50 feature extractor, we use the average
pooling operation. Then, we use another one fully connected
layer to reduce the channel number to 1024, followed by
three fully connected layers (channel number: 1024, 256, 128)
for DR and DME grading, respectively. The dropout layer is
also employed. For [11], we use a fully connected layer with
channel size 256 to concatenate the information from one task
to another task, then two individual fully connected layers are
employed for final DR and DME grading, respectively.
We report the performance of these two methods in Table V.
It is observed that our method clearly outperforms these multi-
task learning based methods on the Joint Accuracy metric.
Compared with [11], our method achieves 1.4% (AUC) and
2.3% (Ac) improvement for DR; 1.8% (AUC) and 0.8% (Ac)
improvement for DME. These results show the superiority of
our framework for joint DR and DME grading.
E. Comparisons on the Messidor Dataset
We also compare our method with other DR grading models
and DME grading models reported on the Messidor dataset
in Table VII. As described in section II, there are two main
branches for DR grading: employing both image-level and
lesion location information as the supervision [32, 33, 53, 54],
and employing only image-level supervision [48, 49, 35]. As
for DME grading, some works [38, 6, 7] utilized macular
or lesion location information features to help the grading
Table VII: Results of different methods on the Messidor
dataset. Our result is under 10-fold cross validation. Other
results are copied from original papers. “-” indicates no
reported result.
Methods DR DMEAUC Ac AUC Ac
Lesion-based [50] 76.0 - - -
Fisher Vector [50] 86.3 - - -
VNXK/LGI [49] 88.7 89.3 - -
CKML Net/LGI [49] 89.1 89.7 - -
Comprehensive CAD [48] 91.0 - - -
DSF-RFcara [20] 91.6 - - -
Clinical B [48] 92.0 - - -
Clinical A [48] 94.0 - - -
Zoom-in-net [35] † 95.7 91.1 - -
DME classifier [39] - - - 88.8
CANet (ours) 96.3 92.6 92.4 91.2
“†”: denotes using additional dataset EyePACS [52] as the pretrain.
of DME. For fair comparison, we only compare with those
methods with only image-level supervision.
For DR grading models, the combined kernels with multiple
losses network (CKML) [49] and VGGNet with extra kernels
(VNXK) [49] aims to employ multiple filter sizes to learn fine-
grained discriminant features. Moreover, clinical experts [48]
were also invited to grade on the Messidor dataset. It is worth
mentioning that our method outperforms the clinical experts
by 2.3% abd 4.3% on the AUC metric. Note that the clinical
experts are provided by specific expert in [48]. Recently,
Wang et al. [35] proposed the gated attention model and
combined three sub-networks to classify the holistic image,
high-resolution crops and gated regions. It is worth noticing
that they first pretrain their model on EyePACS dataset [52]
and then fine tune on the Messidor dataset, while we only
use the Messidar dataset to train our model. Our method with
cross-disease attention module further pushes the result, which
obtains 1.5% Ac and 0.6% AUC gain over Zoom-in-net. For
DME grading, our model excels the other reported results [39]
by 2.4% improvement on Ac metric.
F. Results on the IDRiD Challenge Leaderboard
Table VIII shows the results of our method and other chal-
lenge participation methods on the IDRiD challenge dataset.3
Our model is trained with only the data in the Sub-challenge
2 (image-level supervision). It is observed that our model
achieves a joint accuracy of 65.1%, which is higher than the
top-ranked result by LzyUNCC (an unpublished work) on the
leaderboard, with a relative 2.0% improvement on the joint
3Challenge results are in https://idrid.grand-challenge.org/Leaderboard/
9DR    2: 0.00 0.00 0.92 0.07 0.00
DME 2: 0.00 0.00 1.00
DR    0: 0.69 0.23 0.07 0.00 0.00
DME 0: 0.85 0.10 0.04
DR    3: 0.00 0.00 0.06 0.73 0.20
DME 2: 0.00 0.00 0.99
DR    2: 0.00 0.00 0.99 0.01 0.00
DME 2: 0.00 0.08 0.92
DR    3: 0.00 0.00 0.00 0.64 0.35
DME 2: 0.00 0.00 0.99
DR    4: 0.00 0.00 0.00 0.05 0.95
DME 2: 0.00 0.10 0.90
DR    2: 0.00 0.00 0.99 0.00 0.00
DME 2: 0.00 0.14 0.86
DR    2: 0.07 0.00 0.86 0.00 0.07
DME 1: 0.05 0.95 0.00
Figure 5: Visual results of our method on the test set in the IDRiD dataset. We list the ground-truth, followed by the prediction
score for different severity for each individual disease in a sequential order (0-4 for DR and 0-2 for DME). Blue indicates our
predicted grade and green box indicates the ground-truth.
Table VIII: Comparison with the reported results on the IDRiD
leaderboard. (unit: %)
Methods Joint Ac Rank
CANet (ours) 65.1 1
lzyuncc 63.1 2
VRT 55.3 3
Mammoth 51.5 4
HarangiM1 47.6 5
AVSASVA 47.6 5
HarangiM2 40.8 6
accuracy. Lastly, it is worth noting that we trained our model
using only the data in Sub-challenge 2 in the IDRiD dataset,
while others (unpublished works) may use model ensembles
or other supervision provided in other Sub-challenges.
We also analyze the effect of each attention module on the
IDRiD dataset, and the results are shown in Table IX. With
only disease-specific attention modules (CANet (d-S only)),
our method excels the joint training baseline by 1%. Two
disease-dependent modules “CANet (d-S, d-D DR⇒DME)” and
“CANet (d-S, d-D DR⇐DME)” both further improve the joint
grading performance by exploring the dependence between
these two diseases. We can also observe that DME has much
influences for the grading of DR, and this observation is
consistent with that in the Messidor dataset in Table IV.
With both direction dependent attention modules, our method
achieves the best performance with Joint Ac 65.1%. Finally,
we visualize some examples of the disease prediction score
of our method on the IDRiD dataset in Figure 5. We can see
that our method clearly differentiates the severity for DR and
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Figure 6: The learning curves of our method on the Messidor
dataset (a) and IDRiD dataset (b).
Table IX: Results on the IDRiD dataset with different attention
modules setting. (unit: %)
Methods Joint Ac
Joint training 59.2
CANet (d-S only) 60.2
CANet (d-S, d-D DR⇒DME ) 62.1
CANet (d-S, d-D DR⇐DME ) 63.1
CANet (final model) 65.1
DME, respectively. As shown in Figure 6, we visualize the
learning curves of our method on the Messidor dataset and
IDRiD dataset, respectively.
V. DISCUSSION
Recently, with the advances of deep learning techniques,
automatic grading of DR and DME has been widely studied
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in the research community [6, 7, 38, 54, 53, 33, 32, 55, 35].
Although the large improvements have been achieved on these
tasks, to the best of our knowledge, there is no previous works
that jointly grade these two diseases and model the relationship
between them. In this work, we investigate the importance of
the relationship between DR and DME for the joint grading
task, and propose a cross-disease attention network (CANet)
to capture the relationship between these two diseases. One
method consists of two kinds of attention modules: one to
learn disease-specific features and another to learn disease-
dependent features. Results shown on two public benchmark
datasets, i.e., the Messidor dataset and 2018 ISBI IDRiD
dataset, demonstrated the effectiveness of our method.
Although the good performance achieves, the limitation of
our method still exists. The whole network is trained with
only image-level supervision, making it very challenging to
find the accurate abnormal signs, such as soft exudates, hard
exudates, microaneurysms, and hemorrhage. The lesion masks
or bounding boxes would provide the location information of
these abnormal signs, which would be largely beneficial to
the grading tasks [32, 33, 56], since the severity is usually
based on the lesions. However, we are not aware of any public
datasets containing both DR, DME grading labels, as well
as the lesion or abnormal region segmentation masks. One
solution is to collect the datasets with massive annotations, i.e.,
lesion masks and the grading labels of multi-diseases. Another
feasible solution is to explore how to utilize the lesion segmen-
tation information from additional datasets to help the joint DR
and DME grading. The dataset with lesion masks and dataset
with DR & DME grading labels may have domain shifts, and
generative adversarial networks [57–60] will be beneficial for
this task.
Our method is feasible to extend to more correlated diseases.
The attention mechanism aims to learn the attentional weights
among multiple diseases. If we have multiple correlated dis-
eases, the architecture will have multiple outputs, and each
of them is optimized by an individual loss function to obtain
the disease-specific features. Moreover, the disease-dependent
attention module can be added to these diseases. For example,
if there are five correlated diseases, 20 disease-dependent
attention modules should be designed, and each module learns
the correlation between every two diseases. Due to the high
computational cost, the limitations would be the effective
design of such attention blocks.
The future direction we would like to work on is to better
model the relationship between DR and its complication DME,
and also explore the relationship of multi-diseases occurred
in one image. One potential research direction is to use
the graph convolutional neural network [61] to model the
relationship among different diseases. Through this, we hope
to leverage the correlative information to improve joint grading
performance. Also, it might bring some new insights to help
doctors in understanding the diseases and their complications,
even in a board area of AI medicine [62, 63].
VI. CONCLUSION
In this work, we present a cross-disease attention network
(CANet) to jointly grade DR and DME, and explore the
individual diseases and also the internal relationship between
two diseases by formulating two attention modules: one to
learn disease-specific features and another to learn disease-
dependent features. After that, the network leverages these two
features simultaneously for DR and DME grading to maximize
the overall grading performance. Experimental results on the
public Messidor dataset demonstrate the superiority of our
network over other related methods on both the DR and DME
grading tasks. Moreover, our method also achieves the best
results on the IDRiD challenge dataset. In the future, we plan
to train our network jointly with the lesion annotations to
further improve the DR and DME grading performance.
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